VanEck Vectors Biotech ETF Stock Forecast, Price & News

Wall Street analysts have given VanEck Vectors Biotech ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but VanEck Vectors Biotech ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

VanEck Vectors Biotech ETF saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 12,200 shares, a drop of 15.3% from the February 28th total of 14,400 shares. Based on an average daily trading volume, of 13,500 shares, the days-to-cover ratio is presently 0.9 days.
View VanEck Vectors Biotech ETF's Short Interest.

VanEck Vectors Biotech ETF's stock was trading at $126.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BBH shares have increased by 38.2% and is now trading at $175.31.
View which stocks have been most impacted by COVID-19.

VanEck Vectors Biotech ETF announced an annual dividend on Friday, December 18th. Investors of record on Tuesday, December 22nd will be paid a dividend of $0.608 per share on Monday, December 28th. This represents a yield of 0.35%. The ex-dividend date of this dividend is Monday, December 21st. This is a positive change from VanEck Vectors Biotech ETF's previous annual dividend of $0.42.
View VanEck Vectors Biotech ETF's dividend history.

VanEck Vectors Biotech ETF pays an annual dividend of $0.61 per share and currently has a dividend yield of 0.34%.
View VanEck Vectors Biotech ETF's dividend history.

Some companies that are related to VanEck Vectors Biotech ETF include PIMCO Corporate & Income Opportunity Fund (PTY), Hercules Capital (HTGC), WisdomTree Emerging Markets High Dividend Fund (DEM), Royce Value Trust (RVT), The Gabelli Equity Trust (GAB), Tri-Continental (TY), Liberty All-Star Equity Fund (USA), iShares MSCI Australia ETF (EWA), Tortoise Energy Infrastructure (TYG), Boulder Growth & Income Fund (BIF), iShares MSCI Hong Kong ETF (EWH), Nuveen Nasdaq 100 Dynamic Overwrite Fund (QQQX), Cornerstone Strategic Value Fund (CLM), Aberdeen Asia-Pacific Income Fund (FAX) and AllianceBernstein Global High Income Fund (AWF).
View all of BBH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), (SNY), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), (MRNA) and Novavax (NVAX).

VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BBH stock can currently be purchased for approximately $175.31.

VanEck Vectors Biotech ETF has a market capitalization of $494.72 million.